Literature DB >> 19757167

Maggot excretions/secretions induces human microvascular endothelial cell migration through AKT1.

Shou-yu Wang1, Kai Wang, Yi Xin, De-cheng Lv.   

Abstract

Maggot therapy is a simple and highly successful method for healing of infected and necrotic wounds. The increasing evidences indicate that Maggot excretions/secretions (ES) plays important roles in the wounds healing process. But the precise molecular mechanisms remain undefined. Herein, we investigated if ES induced cell migration during wound healing process using microvascular endothelial cells (HMEC-1) as model, and this effect was associated with the activation of AKT1 and ERK1/2. Wound healing and transwell migration assays were performed to study the effects of ES on HMEC-1 cell migration. Our data showed that ES significantly induced HMEC-1 cell migration in both wound healing and transwell assays, and time-dependently (P < 0.05) activated AKT1, but not ERK1/2. Moreover LY294002 (a PI3K inhibitor) partially attenuated (P < 0.05) ES-induced cell migration in wound healing assay while completely inhibited (P < 0.05) ES-induced AKT1 activation. These findings demonstrate that ES directly induces HMEC-1 cell migration and this event is partially mediated by the activation of AKT1.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19757167     DOI: 10.1007/s11033-009-9806-x

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  30 in total

1.  Larva therapy in wound management.

Authors:  M Courtenay; J C Church; T J Ryan
Journal:  J R Soc Med       Date:  2000-02       Impact factor: 5.344

Review 2.  Wound healing: an overview.

Authors:  George Broughton; Jeffrey E Janis; Christopher E Attinger
Journal:  Plast Reconstr Surg       Date:  2006-06       Impact factor: 4.730

3.  Recombinant human platelet-derived growth factor enhanced dermal wound healing by a pathway involving ERK and c-fos in diabetic rats.

Authors:  Biao Cheng; Hong-Wei Liu; Xiao-Bing Fu; Tong-Zhu Sun; Zhi-Yong Sheng
Journal:  J Dermatol Sci       Date:  2007-01-31       Impact factor: 4.563

4.  Activation of the phosphatidylinositol 3-kinase/protein kinase Akt pathway mediates CD151-induced endothelial cell proliferation and cell migration.

Authors:  Zhen-Zhong Zheng; Zheng-Xiang Liu
Journal:  Int J Biochem Cell Biol       Date:  2006-09-14       Impact factor: 5.085

5.  Maggots and wound healing: an investigation of the effects of secretions from Lucilia sericata larvae upon the migration of human dermal fibroblasts over a fibronectin-coated surface.

Authors:  Adele J Horobin; Kevin M Shakesheff; David I Pritchard
Journal:  Wound Repair Regen       Date:  2005 Jul-Aug       Impact factor: 3.617

Review 6.  Exploring debridement options for chronic venous leg ulcers.

Authors:  Colin E Davies; Glenda Turton; Gina Woolfrey; Rachel Elley; Maxine Taylor
Journal:  Br J Nurs       Date:  2005 Apr 14-27

7.  MEK/ERK regulates adherens junctions and migration through Rac1.

Authors:  Ramesh M Ray; Rajiv J Vaidya; Leonard R Johnson
Journal:  Cell Motil Cytoskeleton       Date:  2007-03

8.  Greenbottle (Lucilia sericata) larval secretions delivered from a prototype hydrogel wound dressing accelerate the closure of model wounds.

Authors:  Annie G Smith; Rachel A Powis; David I Pritchard; Stephen T Britland
Journal:  Biotechnol Prog       Date:  2006 Nov-Dec

9.  Akt1 controls insulin-driven VEGF biosynthesis from keratinocytes: implications for normal and diabetes-impaired skin repair in mice.

Authors:  Itamar Goren; Elke Müller; Dana Schiefelbein; Paul Gutwein; Oliver Seitz; Josef Pfeilschifter; Stefan Frank
Journal:  J Invest Dermatol       Date:  2008-07-31       Impact factor: 8.551

Review 10.  Biologic therapeutics and molecular profiling to optimize wound healing.

Authors:  Marie N Menke; Nathan B Menke; Cecelia H Boardman; Robert F Diegelmann
Journal:  Gynecol Oncol       Date:  2008-10-01       Impact factor: 5.482

View more
  8 in total

1.  Evaluation of anti-bacterial and wound healing activity of the fruits of Amorpha fruticosa L.

Authors:  Xueling Qu; Yunpeng Diao; Zhen Zhang; Shouyu Wang; Yujie Jia
Journal:  Afr J Tradit Complement Altern Med       Date:  2013-04-12

Review 2.  TIME management by medicinal larvae.

Authors:  David I Pritchard; Václav Čeřovský; Yamni Nigam; Samantha F Pickles; Gwendolyn Cazander; Peter H Nibbering; Anke Bültemann; Wilhelm Jung
Journal:  Int Wound J       Date:  2015-07-15       Impact factor: 3.315

3.  Histological patterns in healing chronic wounds using Cochliomyia macellaria (Diptera: Calliphoridae) larvae and other therapeutic measures.

Authors:  Franciéle Souza de Masiero; Mariana Prado Nassu; Mauro Pereira Soares; Patricia Jacqueline Thyssen
Journal:  Parasitol Res       Date:  2015-04-24       Impact factor: 2.289

4.  Luteolin suppresses growth and migration of human lung cancer cells.

Authors:  Yunxue Zhao; Guotao Yang; Dongmei Ren; Xiumei Zhang; Qiuwei Yin; Xuefei Sun
Journal:  Mol Biol Rep       Date:  2010-06-30       Impact factor: 2.316

5.  Fatty acid extracts from Lucilia sericata larvae promote murine cutaneous wound healing by angiogenic activity.

Authors:  Zhen Zhang; Shouyu Wang; Yunpeng Diao; Jianing Zhang; Decheng Lv
Journal:  Lipids Health Dis       Date:  2010-03-08       Impact factor: 3.876

Review 6.  Traditional Therapies for Skin Wound Healing.

Authors:  Rúben F Pereira; Paulo J Bártolo
Journal:  Adv Wound Care (New Rochelle)       Date:  2016-05-01       Impact factor: 4.730

Review 7.  Pharmacological Properties of the Medical Maggot: A Novel Therapy Overview.

Authors:  Litao Yan; Jin Chu; Mingshu Li; Xianfeng Wang; Junwei Zong; Xueyang Zhang; Mingzhi Song; Shouyu Wang
Journal:  Evid Based Complement Alternat Med       Date:  2018-05-03       Impact factor: 2.629

8.  Luteolin inhibits migration of human glioblastoma U-87 MG and T98G cells through downregulation of Cdc42 expression and PI3K/AKT activity.

Authors:  Wen-Yu Cheng; Ming-Tsang Chiao; Yea-Jiuen Liang; Yi-Chin Yang; Chiung-Chyi Shen; Chiou-Ying Yang
Journal:  Mol Biol Rep       Date:  2013-05-16       Impact factor: 2.316

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.